GigNet Names Angel R Gonzalez as New Chief Financial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Brings Deep Expertise in Corporate Strategy, Business Development and Commercialization
PHILADELPHIA, May 06, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD) today announced the appointment of Sébastien Martel as Senior Vice President of Strategy and Business Development. Mr. Martel will lead the Company’s corporate strategy and business and corporate development endeavors. He will be a member of the Amicus senior leadership team.
Mr. Martel brings 25 years of diversified pharmaceutical and biotechnology expertise to Amicus, with extensive experience in rare disease, most recently as Senior Vice President, Global Head of Rare Diseases at Sanofi. Mr. Martel has played a key role in managing the launch and growth of several products across therapeutic areas and has had significant involvement in strategic merger and acquisition transactions and business development deals. He brings a proven track record in corporate and business development, global marketing, product